Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer

Fibrinolysis and Proteolysis

Volumn 4, Issue 2, 1990, Pages 69-78

  Janicke F ^a   Schmitt, M ^a   Hafter, R ^a   Hollrieder, A ^a   Babic, R ^b   Ulm, K ^c   Gossner W ^b   Graeff, H ^a  

^a F Jänicke M Schmitt R Hafter A Holhieder H Graeff Frauenklinik and Poliklinik FRG ^*

^b R Babic W Gossner Institut für Allgemeine Pathologie and Pathologische Anatomic FRG ^*

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; FEMALE; HISTOCHEMISTRY; HUMAN;

EID: 0025127815     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/0268-9499(90)90001-Z     Document Type: Article

References (40)

1. Epidermal growth factor receptors and oestrogen receptors in human breast cancer
2. Plasminogen activators tissue degradation and cancer
3. The relevance of plasminogen activators to neoplastic growth. A review of recent literature
4. Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture
5. Plasminogen activator content of human colon tumors and normal mucosae; separation of two enzymes and partial purification
6. Content and characterization of plasminogen activators in human lung cancer and normal lung tissue
7. Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity
8. Plasminogen activator activity and composition in human breast cancer
9. Surface receptors for urokinase plasminogen activator
10. Tumors Wounds that do not heal Similarities between tumor stroma generation and wound healing
11. Clinical aspects of fibrinolysis
12. Fibrin-Fibronectin compounds in human ovarian tumor ascites and their possible relation to the tumor stroma
13. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane
14. Antibodies to plasminogen activator inhibit human tumor metastasis
15. Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas
16. Proliferation of a human epidermal tumor cell line stimulated by urokinase
17. Effect of urokinase on the proliferation of primary cultures of human prostatic cells
18. Tumor-associated fibrinolysis in human breast cancer: Quantitative assessment of urokinase (u-PA) in tumor tissues and immunohistochemical localisation
19. Regression models and life-tables
20. Testing a sequence of observations for a shift in location
21. A comparison of estimated proportional hazards models and regression trees
22. Bootstrap Investigation of the stability of a Cox regression model
23. Nonparametric estimation from incomplete observations
24. Evaluation of survival data and two new rank order statistics arising in its consideration
25. Tissue plasminogen activator and urokinase in normal dysplastic and cancerous squamous epithelium of the uterine cervix
26. Comparison of the immunohistochemical localisation of urokinase in normal and cancerous human colon tissue
27. The urokinase type of plasminogen activator in cancer of digestive tract
28. Urokinaseplasminogen activator, a marker for aggressive breast carcinomas. Preliminary report
29. Urokinase—the enzyme responsible for invasion and metastasis in human breast carcinoma?
30. Plasminogen activator profiles in neoplastic tissues of the human colon
31. Tissue plasminogen activator activity in prostatic cancer
32. Plasminogen activator content of gynecological tumors and their metastases
33. Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7)
34. Bioactivities, estrogen receptor interactions, and plasminogen Activator-inducing activities of tamoxifen and hydroxytamoxifen isomers in MCF-7 human breast cancer cells
35. Hormonal control of plasminogen activator secretion in ZR-75-1 human breast cancer cells in culture
36. Determination of the effect of epidermal growth factor on urokinase secretion and urokinase receptor display in a well-differentiated human colon carcinoma cell line
37. Down regulation of epidermal growth factor receptor correlates with plasminogen activator activity in human A431 epidermoid carcinoma cells
38. Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor β